Literature DB >> 17846412

Structural and functional MRIs disclose cerebellar pathologies in idiopathic downbeat nystagmus.

K Hüfner1, T Stephan, R Kalla, A Deutschländer, J Wagner, M Holtmannspötter, G Schulte-Altedorneburg, M Strupp, T Brandt, S Glasauer.   

Abstract

BACKGROUND: Neurologic disorders in which the etiology and pathogenesis are not yet understood are termed idiopathic. Downbeat nystagmus (DBN) is a frequent eye movement disorder that clinically manifests with oscillopsia and postural instability. Forty percent of patients with DBN are classified as having idiopathic DBN, because no underlying pathology can be demonstrated by conventional MRI or laboratory tests.
METHODS: We evaluated gray matter brain volumes of 11 patients with idiopathic DBN and compared them to those of healthy controls using voxel-based morphometry. In a second, functional MRI experiment, patients and controls performed downward smooth pursuit eye movements (DOWN), which were then compared with straight-ahead fixation of a stationary target (MID).
RESULTS: Small areas of localized gray matter atrophy were detected in the lateral cerebellar hemispheres (lobule VI) and ocular motor vermis of patients with idiopathic DBN, but not in the flocculus and paraflocculus. The functional imaging data, however, revealed reduced activation in the parafloccular lobule and in the ponto-medullary brainstem of the patients when they performed smooth pursuit eye movements downwards.
CONCLUSIONS: The applied specialized imaging and data analysis techniques disclosed pathologies in an idiopathic eye movement disorder. The focal atrophy found in the vermal and lateral cerebellar regions in downbeat nystagmus (DBN) may lead to deficits in smooth pursuit eye movement initiation, which in turn causes hypofunction of the parafloccular lobe, associated with DBN. Our data are in line with experiments in primates showing that ablation of the floccular and parafloccular lobes disrupts smooth pursuit and causes DBN.

Entities:  

Mesh:

Year:  2007        PMID: 17846412     DOI: 10.1212/01.wnl.0000276953.00969.48

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Current treatment of vestibular, ocular motor disorders and nystagmus.

Authors:  Michael Strupp; Thomas Brandt
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

2.  [Ocular motility disorders in a patient with Fabry's disease].

Authors:  B Fiore; M Klopfer; C Schwebig; A Wiescher; I Lanzl
Journal:  Ophthalmologe       Date:  2009-06       Impact factor: 1.059

3.  Downbeat nystagmus as the initial manifestation of anti-NMDAR encephalitis.

Authors:  Yohei Tsuyusaki; Ryuji Sakakibara; Masahiko Kishi; Fuyuki Tateno; Tomoe Yoshida
Journal:  Neurol Sci       Date:  2013-07-28       Impact factor: 3.307

4.  Downbeat nystagmus: evidence for enhancement of utriculo-ocular pathways by ocular vestibular evoked myogenic potentials?

Authors:  Tatiana Bremova; Stefan Glasauer; Michael Strupp
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-30       Impact factor: 2.503

5.  Dalfampridine in patients with downbeat nystagmus--an observational study.

Authors:  Jens Claassen; Katharina Feil; Stanislav Bardins; Julian Teufel; Rainer Spiegel; Roger Kalla; Erich Schneider; Klaus Jahn; Roman Schniepp; Michael Strupp
Journal:  J Neurol       Date:  2013-04-16       Impact factor: 4.849

6.  Enhancement of the bias component of downbeat nystagmus after lesions of the nodulus and uvula.

Authors:  Mark F Walker; Jing Tian; Xiaoyan Shan; Howard Ying; Rafael J Tamargo; David S Zee
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

Review 7.  [Pharmacotherapy of central oculomotor disorders].

Authors:  R Kalla; R Spiegel; J Wagner; N Rettinger; K Jahn; M Strupp
Journal:  Nervenarzt       Date:  2008-12       Impact factor: 1.214

Review 8.  Conversion of upbeat to downbeat nystagmus in Wernicke encephalopathy.

Authors:  Jorge C Kattah; Ali Saber Tehrani; Sascha du Lac; David E Newman-Toker; David S Zee
Journal:  Neurology       Date:  2018-10-23       Impact factor: 9.910

9.  Lesions of the cerebellar nodulus and uvula impair downward pursuit.

Authors:  Mark F Walker; Jing Tian; Xiaoyan Shan; Rafael J Tamargo; Howard Ying; David S Zee
Journal:  J Neurophysiol       Date:  2008-07-23       Impact factor: 2.714

10.  The ataxic mouse as a model for studying downbeat nystagmus.

Authors:  John S Stahl; Zachary C Thumser; Brian S Oommen
Journal:  J Vestib Res       Date:  2012       Impact factor: 2.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.